All News

Study finds that the use of biologics and other potentially immunocompromising therapies for atopic dermatitis was associated with low risk of severe COVID-19.

Access to buprenorphine among Medicaid beneficiaries was not affected during the pandemic.

Prurigo nodularis causes intense, persistent itch, with thick skin nodules that can cover most of the body.

Curtailing the availability of meth precursors in the principal focus of the law, paving the way for states to follow suit.

Patients in the atogepant 60 mg daily and 30 mg twice daily treatment arms of the study experienced a decrease of 6.88 and 7.46 monthly migraine days, respectively.

Baricitinib (Olumiant; Eli Lilly and Incyte ) was found to produce significant hair regrowth on the scalp, eyelashes, and eyebrows of adults with severe alopecia areata.

Electronic, open loop, clinical decision support system helped to produce a 38% lower overall mortality rate among patients with pneumonia.

Trastuzumab (Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant) is a HER2/neu receptor antagonist indicated for early and advanced breast cancer, advanced stomach cancer, and gastroesophageal junction cancer.

Theraworx is a foam that offers relief from muscle cramps and spasm.

Acalabrutinib (Calquence; AstraZeneca) provides efficacy while maintaining favorable tolerability for patients with chronic lymphocytic leukemia.

FDA seeks to reduce diversion of pharmaceutical products via sales by unlicensed distributers and tighten up the supply chain by vetting trading partners.

Students from the University of the Sciences Philadelphia College of Pharmacy and the Rutgers University Ernest Mario School of Pharmacy went head-to-head to answer questions about the pharmacy field.

Heat waves, which are on the rise, appear to pose particular cardiovascular risk for Black populations and men, new study results show.

In proposed changes, the practice would fall within nonsterile compounding.

FDA approves label update for Cabenuva that makes the therapy’s oral lead-in with cabotegravir and rilpivirine tablets optional.

RSVpreF gets breakthrough designation for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age or older.

Most other compounds undergoing clinical trials target testosterone, which can lead to depression, higher low-density lipoprotein cholesterol levels, and weight gains.

Donepezil (Aricept) is an acetylcholinesterase inhibitor indicated for the treatment of dementia related to Alzheimer disease.

Pataday ophthalmic solution is an antihistamine that can help reduce itch and redness in the eyes.

In episode 9, Suzanne Soliman, PharmD, BCMAS, discussed pharmacogenomics with 3 special guests.

The Fellowship Program is able to help pharmacies get to scale and helps pharmacists get plugged into independent enhanced services.

Larry Buie, PharmD, BCOP, FASHP, outgoing president of the Hematology/Oncology Pharmacy Association (HOPA), shares some details of HOPA’s upcoming 2022 annual conference in Boston and provides an overview of his term as HOPA’s president.

Many of the medications used in the treatment of erectile dysfunction have interactions with other medications, so it is crucial for pharmacists to carefully examine patient profiles to optimize therapy and ensure safety.

New study results focus on blood pressure, blood sugar, and cholesterol levels; body mass index; and smoking status when individuals have bipolar or schizoaffective disorder or schizophrenia.

Investigators also identified that a polymerase inhibitor with a unique modification largely resists its removal from the RNA by the exonuclease.

Pharmacy Times spoke with students at the Idaho State University College of Pharmacy and its partner program at the University of Alaska Anchorage College of Health.

Osimertinib (Tagrisso; AstraZeneca) is FDA approved for 3 unique cancer indications.

Leveraging automation capabilities and operational capacity at scale, they bridge gaps and mitigate the impact of disruptions.

Thirty minutes of day of movement, such as walking, can help break the cycle of inflammation that causes symptoms even 6 months later.